Webinar hosted by Revvity
Date: June 27, 2024
Time: 10 AM PT | 1 PM ET | 6 PM BT
Key discissions:
- An overview of Just-Evotec Biologics’ integrated approach to antibody production in continuous perfusion bioreactors, including the use of analytical tools to facilitate early-stage clone screening.
- The use of Just-Evotec Biologics’ platform technology to design antibodies against infectious disease targets and expression of products using Revvity’s CHOSOURCE GS KO cell line.
Presented by Yiting Lim, PhD, Senior Scientist, Cell Line Development at Just-Evotec Biologics
